Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clingen Thrombosis Variant Curation Expert Panel, |
RCV001483253 | SCV005061627 | likely benign | Hereditary antithrombin deficiency | 2024-05-09 | reviewed by expert panel | curation | The c.1254C>T (NM_000488.4) variant in SERPINC1 does not code for a different amino acid (p.Thr418=). SpliceAI predicts no splicing impact for this variant meeting BP4. The variant is not predicted to cause a splicing impact and the nucleotide is weakly/moderately conserved with a PhyloP score of -1.569 and a PhastCons score of 0.013 meeting BP7 criteria (PhyloP < 0.1). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Thrombosis Variant Curation Expert Panel for SERPINC1: BP4, BP7. |
Labcorp Genetics |
RCV001483253 | SCV001687638 | likely benign | Hereditary antithrombin deficiency | 2025-02-03 | criteria provided, single submitter | clinical testing |